ISRCTN38929731
Completed
Not Applicable
Comparison of radical radiotherapy with or without chemotherapy for poor prognosis carcinoma of cervix
Cancer Research UK (CRUK) (UK)0 sites0 target enrollmentJuly 1, 2001
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cervix cancer
- Sponsor
- Cancer Research UK (CRUK) (UK)
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Histologically diagnosed squamous cell carcinoma of the cervix uteri
- •2\. International Federation of Gynecology and Obstetrics (FIGO) stage III, IVa or bulky stage II
- •3\. No evidence of extra pelvic spread
- •4\. Aged \<70 years
- •5\. World Health Organisation (WHO) performance 0\-2
- •6\. Suitable for radical radiotherapy
- •7\. Suitable for chemotherapy
- •8\. Adequate haematological and renal function
- •9\. No history of previous malignancy, excluding successfully treated squamous and basal cell carcinoma of skin or carcinoma in situ of the cervix
- •10\. No previous chemotherapy or radiotherapy
Exclusion Criteria
- •Not provided at time of registration
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A trial to compare radiotherapy alone with radiotherapy followed by chemotherapy in the treatment of non-Hodgkin's lymphomaymphoma (non-Hodgkin's)CancerLymphoma (non-Hodgkin's)ISRCTN18173987Cancer Research UK (CRUK) (UK)
Active, not recruiting
Phase 1
ABiochemically-relapsing prostate adenocarcinoma following radical prostatectomy.MedDRA version: 14.1 Level: LLT Classification code 10001186 Term: Adenocarcinoma of prostate System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2011-004831-30-FRICANCER43
Recruiting
Phase 2
Radiotherapy to all involved sites in advanced prostate cancerHealth Condition 1: C61- Malignant neoplasm of prostateCTRI/2022/10/046239Intramural Tata memorial Centre
Recruiting
Phase 2
Radiotherapy of soft tissue sarcomaIRCT20180919041070N3Iran University of Medical Sciences80
Completed
Not Applicable
A randomised trial of radiotherapy alone versus three cycles of cyclophosphamide, doxorubicin, vincristine and prednisolone (CHOP) chemotherapy plus radiotherapy versus six cycles of CHOP chemotherapy plus radiotherapy for early stage aggressive non-Hodgkin's lymphomaon-Hodgkin's lymphomaCancerNon-Hodgkin's lymphomaISRCTN55593137Cancer Research UK (CRUK) (UK)